Actual developments in European regulatory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe?

Ann Oncol. 2014 Feb;25(2):303-6. doi: 10.1093/annonc/mdt488. Epub 2013 Dec 10.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / economics
  • Antineoplastic Agents / therapeutic use*
  • Drug Screening Assays, Antitumor
  • Europe
  • Humans
  • Neoplasms / drug therapy*
  • Technology Assessment, Biomedical*

Substances

  • Antineoplastic Agents